Value of improved nursing measures and enhanced nursing management to reduce the occurrence of adverse events in pediatric infusion

Table 1 Comparison of general data between the two groups

Group	n	Gender, n (%)	Age (mean ± SD)	Infusion time [(mean ± SD), d], χ2	Admission diagnosis disease type, n (%)
		Male /Female			Respiratory diseases	Digestive system diseases	Nervous system disease	Urinary system disease
Control group	65	35 (53.85)/30 (46.15)	6.89 ± 2.12	5.85 ± 1.47	34 (52.31)	23 (35.38)	5 (7.69)	3 (4.62)
Observation group	65	33 (50.77)/32 (49.23)	6.82 ± 2.24	5.92 ± 1.43	32 (49.23)	24 (36.92)	7 (10.77)	2 (3.08)
χ2/t		0.123	0.160	0.241	0.615
P value		0.725	0.873	0.810	0.893